Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Alternatives to Laboratory Animals : ATLA|October 17, 2012
The botulinum toxin LD50 potency assay - another chapter, another mysteryAndy PickettToxicon : Official Journal of the International Society on Toxinology|April 1, 2009
Dysport: pharmacological properties and factors that influence toxin actionAndy PickettBiodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 14, 2010
Re-engineering clostridial neurotoxins for the treatment of chronic pain: current status and future prospectsAndy PickettJournal of Drugs in Dermatology : JDD|September 28, 2010
Formulation composition of botulinum toxins in clinical useAndy Pickett, Karen PerrowToxins|November 10, 2011
Towards new uses of botulinum toxin as a novel therapeutic toolAndy Pickett, Karen PerrowFacial Plastic Surgery Clinics of North America|November 11, 2009
Discussion regarding botulinum toxin, immunologic considerations with long-term repeated use, with emphasis on cosmetic applications. Minimal risk of antibody formation after aesthetic treatment with type a botulinum toxinAndy Pickett, David CairdThe International Journal of Neuroscience|January 20, 2011
New trends in the science of botulinum toxin-A as applied in dystoniaAndy Pickett, Raymond L RosalesAesthetic Surgery Journal|December 1, 2009
The science and manufacturing behind botulinum neurotoxin type A-ABO in clinical useMitchell S Wortzman, Andy PickettAesthetic Surgery Journal|April 8, 2017
AbobotulinumtoxinA: A 25-Year HistoryGary D Monheit, Andy PickettAesthetic Surgery Journal|April 8, 2017
Key Parameters for the Use of AbobotulinumtoxinA in Aesthetics: Onset and DurationMark Nestor, Glynis Ablon, Andy PickettPageof 2